Nathan Lee

Nathan Lee is an accomplished cancer biologist currently serving as the Executive Director of Cancer Biology at Riva Therapeutics since September 2022. Prior to this role, Nathan held various positions at Turning Point Therapeutics, including Director of Cancer Biology & Translational Research and Senior Principal Scientist from October 2019 to October 2022. Nathan’s extensive experience also includes over a decade at Pfizer, where key contributions as Principal Scientist encompassed leadership in early discovery cell cycle programs and collaboration on brain-penetrant CDK4/6 inhibitors. Nathan's research background includes postdoctoral fellowships at Pfizer and UCLA, focusing on molecular profiling and anti-angiogenic mechanisms. Nathan earned a PhD in Cellular and Molecular Biology from UCLA and a Bachelor's degree in a similar field from UC San Diego.